T Berhane1, G M Halliday, B Cooke, R St C Barnetson. 1. Department of Medicine (Dermatology), Melanoma and Skin Cancer Research Institute, University of Sydney at Royal Prince Alfred Hospital, Sydney, Camperdown, NSW 2050, Australia.
Abstract
BACKGROUND: Squamous cell carcinoma (SCC) is a common skin tumour that may metastasize and lead to death. We have observed that before actinic keratoses (AK) progress to SCCs they may become tender and inflamed. In some of these, histological examination shows that they are, in fact, SCCs. OBJECTIVES: To study the progression of AK to SCCs. METHODS: We studied skin tumours from 50 patients with either asymptomatic AK, inflamed AK or SCCs, using immunocytochemistry. The diagnosis of each tumour was confirmed by histological examination. RESULTS: Studies of differentiation using heat shock protein 27 showed a stepwise loss of differentiation as the tumours progressed from asymptomatic AK, through inflamed AK to SCCs. During the inflamed AK phase, there was a marked increase in T lymphocytes and Langerhans cells: the number of infiltrating cells diminished as progression to SCC occurred. There was an increase in immunoreactive p53 and the apoptosis inhibitor bcl-2 as tumours progressed from AK to SCCs, and a decrease in Fas and Fas ligand. CONCLUSIONS: These studies have shown that progression from benign to malignant tumours may be associated with an inflammatory response, which appears to drive malignant conversion, but subsides rapidly following this conversion.
BACKGROUND:Squamous cell carcinoma (SCC) is a common skin tumour that may metastasize and lead to death. We have observed that before actinic keratoses (AK) progress to SCCs they may become tender and inflamed. In some of these, histological examination shows that they are, in fact, SCCs. OBJECTIVES: To study the progression of AK to SCCs. METHODS: We studied skin tumours from 50 patients with either asymptomatic AK, inflamed AK or SCCs, using immunocytochemistry. The diagnosis of each tumour was confirmed by histological examination. RESULTS: Studies of differentiation using heat shock protein 27 showed a stepwise loss of differentiation as the tumours progressed from asymptomatic AK, through inflamed AK to SCCs. During the inflamed AK phase, there was a marked increase in T lymphocytes and Langerhans cells: the number of infiltrating cells diminished as progression to SCC occurred. There was an increase in immunoreactive p53 and the apoptosis inhibitor bcl-2 as tumours progressed from AK to SCCs, and a decrease in Fas and Fas ligand. CONCLUSIONS: These studies have shown that progression from benign to malignant tumours may be associated with an inflammatory response, which appears to drive malignant conversion, but subsides rapidly following this conversion.
Authors: Nita S Agar; Gary M Halliday; Ross StC Barnetson; Honnavara N Ananthaswamy; Mark Wheeler; Alexandra M Jones Journal: Proc Natl Acad Sci U S A Date: 2004-03-23 Impact factor: 11.205
Authors: Maria H Lind; Björn Rozell; Robert P A Wallin; Max van Hogerlinden; Hans-Gustaf Ljunggren; Rune Toftgård; Inderpreet Sur Journal: Proc Natl Acad Sci U S A Date: 2004-03-25 Impact factor: 11.205
Authors: Andrew Freeman; Jennifer A Bridge; Pirashanthini Maruthayanar; Nana H Overgaard; Ji-Won Jung; Fiona Simpson; Tarl W Prow; H Peter Soyer; Ian H Frazer; Michael Freeman; James W Wells Journal: PLoS One Date: 2014-10-23 Impact factor: 3.240
Authors: Zhen Zeng; Margaret Veitch; Gabrielle A Kelly; Zewen K Tuong; Jazmina G Cruz; Ian H Frazer; James W Wells Journal: Cancers (Basel) Date: 2021-04-28 Impact factor: 6.639